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Abstract
Cancer survivors face several challenges following the completion of active treatment, including 
uncertainty about late effects of treatment and confusion about coordination of follow-up care. 
The authors evaluated patient satisfaction with personalized survivorship care plans designed to 
clarify those issues. The authors enrolled 48 patients with breast cancer and 10 patients with 
colorectal cancer who had completed treatment in the previous two months from an urban 
academic medical center and a rural community hospital. Patient satisfaction with the care plan 
was assessed by telephone interview. Overall, about 80% of patients were very or completely 
satisfied with the care plan, and 90% or more agreed that it was useful, it was easy to understand, 
and the length was appropriate. Most patients reported that the care plan was very or critically 
important to understanding an array of survivorship issues. However, only about half felt that it 
helped them better understand the roles of primary care providers and oncologists in survivorship 
care. The results provide evidence that patients with cancer find high value in personalized 
survivorship care plans, but the plans do not eliminate confusion regarding the coordination of 
follow-up care. Future efforts to improve care plans should focus on better descriptions of how 
survivorship care will be coordinated.
About 12.5 million people in the United States were living with a personal history of cancer 
in 2009, including more than 2.5 million women with breast cancer and more than 1 million 
men and women with colorectal cancer (Howlader et al., 2012). An extensive body of 
research provides evidence that cancer survivors frequently experience late effects from 
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their cancer and its treatment, including psychological distress, pain, impaired organ 
function, sexual dysfunction, cosmetic changes, and limitations in mobility, communication, 
and cognition (Ganz, 2000; Harrington, Hansen, Moskowitz, Todd, & Feuerstein, 2010; 
Hewitt, Greenfield, & Stovall, 2005; Stein, Syrjala, & Andrykowski, 2008; Strieker & 
Jacobs, 2008). A landmark report by the Institute of Medicine (Hewitt et al., 2005) 
recognized that the system of delivering care to the growing number of cancer survivors was 
inadequate. Specifically, it suggested that the transition of medical care following cancer 
treatment often is not well coordinated, and many cancer survivors and providers are 
unaware of late effects and heightened health risks related to the cancer and its treatment. A 
key recommendation of the report was that patients with cancer completing primary 
treatment should be provided with a survivorship care plan that includes a comprehensive 
treatment and care summary and follow-up plan.
Although the Commission on Cancer (2012) added the provision of a survivorship care plan 
to its cancer program standards, sparse evidence exists regarding the effectiveness and 
optimal content of care plans (Salz, Oeffinger, McCabe, Layne, & Bach, 2012). Two small 
studies of personalized survivorship care plans suggested reductions in unmet needs among 
cancer survivors and increased adherence with medical surveillance recommendations 
(Jefford et al., 2011; Oeffinger et al, 2011). However, a randomized trial in Canada 
(Grunfeld et al., 2011) found that early-stage breast cancer survivors who received a 
survivorship care plan experienced no benefit in cancer-related distress, quality of life, 
patient satisfaction, and other measures after one year compared to patients who received 
only a standard discharge visit. Although the findings are limited by a short follow-up time 
and may not be directly generalizable to the United States, they provide impetus for 
additional research on the optimal format and delivery of cancer survivorship care plans 
(Smith & Snyder, 2011).
The authors of the current article conducted a study of survivorship care plans for patients 
with breast or colorectal cancer in an urban academic medical center and a small rural 
community hospital in Vermont. The authors evaluated patients' satisfaction with the 
survivorship care plans and assessed the importance of various domains of the care plan for 
the patient. The results can be used to optimize the future design of care plans, which would 
maximize their usefulness to the patient.
Methods
Study Population
The current study was conducted at two sites: Fletcher Allen Health Care, an academic 
medical center in Burlington, VT, and the Norris Cotton Cancer Center-North, a rural 
extension of Dartmouth-Hitchcock Medical Center located at Northeastern Vermont 
Regional Hospital in St. Johnsbury. Eligible patients had stages 0–III breast cancer or stages 
II–IV colorectal cancer, were aged 18 years and older, and had completed treatment with 
curative intent within the preceding 12 months. The study was approved by the human 
subjects institutional review boards at the University of Vermont and Dartmouth Medical 
School, and all patients provided written informed consent. From January to July 2011, a 
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total of 89 patients were invited to participate in the study and 78 agreed (88%), including 
61 with breast cancer and 17 with colorectal cancer.
Survivorship Care Plans
Survivorship care plans were prepared by advanced practice providers (nurse practitioners 
and physician assistants) in consultation with oncologists at each study site using the 
Survivorship Care Plan Builder software tool developed by Journey Forward™ (Hausman, 
Ganz, Sellers, & Rosenquist, 2011). Each survivorship care plan was developed using the 
Journey Forward templates for breast and colorectal cancer, and contained the following 
domains: a summary of the patient diagnosis, a summary of the patient's treatment, 
information on recommended follow-up tests and secondary cancer prevention, information 
received on late effects of cancer treatments, and a list of national and local health-
promotion resources. The survivorship care plan was delivered to and discussed with 
patients by the advanced practice providers during a care plan visit at the clinic. The visit 
lasted about one hour (range = 45–90 minutes) and occurred about 1–6 months following 
completion of initial oncologic treatment for cancer. The survivorship care plans were 
modified if necessary with patient input and finalized. A copy of the final survivorship care 
plan also was mailed to the patients' primary care providers. Although the care plan was 
added to patient electronic medical records and the oncologists were aware of the study, the 
oncologists were not directly notified of the care plans for their patients.
Data Collection
Telephone interviews were conducted with the patients about two months after the care plan 
visit. As many as 15 attempts were made to contact participants, including calls at varying 
times on weekdays, weeknights, and weekends, as well as voicemails left with a toll-free 
number to return calls. Of the 78 patients who enrolled in the study, 58 (74%) completed a 
telephone interview. The remaining 20 either refused to complete the telephone interview 
(n=6) or could not be contacted (n = 14). Nonrespondents were more likely to be older than 
age 65 years, but had similar patterns of cancer stage and treatment to those who completed 
the interview. The telephone interview included questions to assess the care plan as a whole, 
as well as questions targeted specifically toward the various domains and elements of the 
care plan. A variety of question types were used, including categorical response, Likert 
scale, and open-ended response. Patients also were asked to provide basic demographic 
information including marital status, education, and family income. Medical data, including 
cancer stage, date of diagnosis, and treatment information, were obtained from the patients' 
medical records.
Statistical Analyses
All statistical analyses were conducted using SAS®, version 9. Descriptive statistics were 
prepared for each survey question of interest. For certain questions pertaining to the care 
plan in general, the complete set of response frequencies was described. For other questions, 
response options were collapsed into two groups for analysis. Response options for accuracy 
(“Was it accurate?”) and ease of understanding (“Was it easy to understand?”) of the various 
domains included “yes,” “no,” and “somewhat.” The responses were categorized as agree 
(“yes”) or did not agree (“no” or “somewhat”). Response options for whether the care plan 
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was important in helping to understand general domains of survivorship (e.g., possible late 
effects of treatment) were dichotomized as “very important” or “critically important” and 
“somewhat important” or “not important at all.” Response options for whether the care plan 
was important in helping to understand specific elements of the care plan (e.g., 
recommended frequency of follow-up tests) were dichotomized as agree (“yes”) and did not 
agree (“no” or “not sure”). Tests for interaction by cancer site and facility type were 
conducted using Fisher's exact tests. The 95% confidence intervals were constructed using 
the Clopper-Pearson method for exact confidence limits for a binomial proportion (Clopper 
& Pearson, 1934).
Results
A total of 58 patients completed the interview, including 48 with breast cancer and 10 with 
colorectal cancer. The median age of participants was 54 years (range = 35–75 years) among 
patients with breast cancer and 59 years (range = 41–70 years) among patients with 
colorectal cancer. All patients were non-Hispanic Whites, 74% were married or living as a 
couple, and more than 85% reported good, very good, or excellent health. Compared to 
patients with breast cancer, the patients with colorectal cancer were more likely to be aged 
65 years and older, have less education, have more advanced cancers, and to have received 
chemotherapy (see Table 1).
In general, all patients were highly satisfied with the survivorship care plans (see Table 2). 
Among both cancer types, 46 patients (79%) were very or completely satisfied with the care 
plan, 53 (91%) agreed that the care plan was useful and easy to understand, and 54 (91%) 
said that the length was just right. Almost all patients found the in-person care plan visit 
useful and would recommend a care plan to others. However, seven patients with breast 
cancer (12%) and four patients with colorectal cancer (40%) reported that they would need 
help using the care plan. No statistically significant differences were noted in responses to 
these items between patients with breast or colorectal cancer (all p interaction ≥ 0.18).
When examined according to facility type, similar results for all patients combined (breast 
and colorectal) were obtained for the urban academic medical center (n = 37) and the rural 
community hospital (n = 21), with the exception of ease of understanding the care plan (data 
not shown). At the urban academic medical center, 30 patients (81%) strongly agreed and 
seven patients (19%) agreed that the care plan was easy to understand, compared to 10 
(48%) and 9 (43%) at the rural community hospital, respectively, where an additional two 
patients (10%) neither agreed nor disagreed (p interaction = 0.01).
Analyses of specific care plan domains revealed that each section was rated very highly for 
accuracy and ease of understanding, with the exception of which doctor will order tests for 
recurrences or new cancers (see Table 3). Only 28 patients with breast cancer (58%) and 
seven with colorectal cancer (70%) understood which doctor would order these tests. About 
50%–70% of patients with breast cancer reported that the care plan was very or critically 
important to helping them understand the various domains covered by the care plan. High 
levels of importance (80%–100%) were reported among patients with colorectal cancer. All 
patients reported that the section on tests needed in the future was the most important section 
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for improving their understanding. Analyses according to facility type revealed no 
statistically significant differences, although a higher proportion of patients at the rural 
community hospital (n = 14,74%) found the care plan very or critically important for 
understanding their diagnosis compared to patients at the academic medical center (n = 
17,49%) (p interaction = 0.09; data not shown).
The helpfulness of specific aspects of the care plan was further evaluated in the survey (see 
Figure 1). Among patients with breast cancer, 36 (75%) reported that the care plan helped 
them better understand the need for follow-up visits to check for late effects and 35 (73%) 
reported that the care plan helped them better understand the importance of health-
promoting practices following cancer treatment. For patients with breast cancer, the care 
plan was least helpful for understanding the frequency of follow-up tests (n = 25, 52%, 
found it helpful), how their primary care providers and oncologists will work together (n = 
25, 52%), and the role of the primary care provider in their survivorship care (n = 24, 50%). 
Patients with colorectal cancer reported generally high levels of helpfulness for all elements, 
with the exception of their primary care providers' role in survivorship care (n = 4, 40%). 
The differences in those responses between patients with breast and colorectal cancer were 
not statistically significant. Analyses across facility type revealed that patients at the rural 
community hospital were more likely to find the care plan helpful in understanding how 
primary care providers and oncologists work together and the role of their primary care 
provider in survivorship care (n = 15 [71%] for both) than patients at the academic medical 
center (n = 18 [49%] and n = 13 [35%] patients, respectively) (p interaction = 0.1 and 0.03, 
respectively; data not shown).
Discussion
The current study found that patients with breast or colorectal cancer in academic and rural 
study sites in Vermont reported high satisfaction with survivorship care plans designed 
using the Survivorship Care Plan Builder from Journey Forward. The care plans were rated 
very highly for usefulness, ease of understanding, and accuracy, and most patients reported 
that the care plan was very or critically important in helping them understand the various 
domains covered by the care plan. The results suggest that survivorship care plans are useful 
tools for improving patients' understanding of their diagnosis, treatment, survivorship care, 
and health promotion.
The area of the care plan that was least favorably rated was the information regarding the 
coordination of care. Only about half of the patients felt that the care plan helped them better 
understand the role of their primary care provider in survivorship care and how their primary 
care provider and oncologist would work together. The care plan was effective in describing 
the types of tests needed for surveillance for recurrences and new cancers, but a substantial 
proportion of patients still did not understand who would order tests for recurrences or new 
cancers. That limitation of the care plan likely reflects the uncertainty in the medical 
community regarding the precise roles of oncologists and primary care providers in 
survivorship care (Potosky et al, 2011). A survey by Salz et al. (2012) found that less than 
half of the survivorship care plans in use at National Cancer Institute-designated cancer 
centers indicated the medical provider who should perform specific medical surveillance. In 
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addition, the inclusion of contact information for care coordinators or navigators in 
survivorship care plans is rare (Strieker et al, 2011). The authors' results provide additional 
evidence that an urgent need exists for guidelines from professional societies and other 
organizations that can clarify the role of primary care providers and oncologists in 
survivorship care and reduce uncertainty for providers and patients.
Relationship to Previous Studies
The majority of previous studies regarding patient perspectives on survivorship care plans 
have used qualitative methods to assess patient preferences for survivorship care plans, most 
often by soliciting responses to a sample care plan (Salz et al., 2012). The studies provided 
evidence that survivors prefer the inclusion of information such as diagnosis and treatment, 
expected side effects (physical and psychological), signs and symptoms of recurrence, a 
recommended follow-up schedule, and resources for health promotion, further information, 
and support (Baravelli et al., 2009; Brennan, Butow, Marven, Spillane, & Boyle, 2011; 
Burg, Lopez, Dailey, Keller, & Prendergast, 2009; Hewitt, Bamundo, Day, & Harvey, 2007; 
Marbach & Griffie, 2011; Smith, Singh-Carlson, Downie, Payeur, & Wai, 2011). The 
current study provides quantitative evidence that breast and colorectal cancer survivors who 
receive a personalized survivorship care plan find value in those components of the care 
plan. The authors also found that cancer survivors considered the care plan visit highly 
useful. The results are consistent with prior studies suggesting that in-person care plan visits 
are generally positive experiences for patients and can reduce anxiety and stress related to 
cancer (Jefford et al., 2011; Mayer et al., 2012).
In contrast, the focus group studies indicated that patients believe that survivorship care 
plans would be valuable for improving communication among providers of care (Brennan et 
al., 2011; Kantsiper et al., 2009; Marbach & Griffie, 2011). The results suggest that current 
versions of survivorship care plans may not meet that goal.
The majority of previous studies regarding patient perspective on survivorship care plans 
have focused on patients with breast cancer. Unfortunately, the authors of the current article 
were unable to detect differences in care plan satisfaction between patients with breast and 
colorectal cancer because of the small number of patients with colorectal cancer enrolled in 
the current study.
Previous focus group studies have revealed no differences in preferences for care plan 
content among patients living in urban and rural settings (Smith et al., 2011). The authors of 
the current study observed few differences in patient evaluation of the care plan according to 
whether their care was received at an urban academic medical center or a rural community 
hospital, although those comparisons also were limited by a small sample. Patients at the 
community hospital were less likely to strongly agree that the care plan was easy to 
understand, but more than 90% indicated some level of agreement. Patients at the 
community hospital also found the care plan more important for understanding their 
diagnosis and for understanding how care would be coordinated. Some of the differences 
may be attributable to individual level factors such as income and health status, which were 
somewhat lower in the community hospital population. The results also could have been 
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influenced by the style of delivery of the specific advanced practice providers at the two 
study sites.
Limitations
Certain limitations should be considered when interpreting the results of the current study. 
The lack of racial and ethnic diversity of patients seen at these clinics limits the 
generalizability of the results. Although the size of the study population was adequate to 
describe overall satisfaction with the care plans, insufficient power was available to detect 
small differences in responses by cancer type or type of facility. In addition, the participants 
who agreed to take part in the study were slightly younger than the target population of 
cancer survivors at the study clinics and may have differed in other unmeasured ways (e.g., 
attitudes toward medical care). Therefore, the findings require additional exploration in 
larger populations across a variety of healthcare settings.
Although the authors assessed patient satisfaction with the survivorship care plans at a single 
point in time, patient satisfaction with care plans may vary over time. The results should not 
be generalized to settings in which the document is not delivered during an in-person 
medical visit. Finally, responses to a series of questions regarding the helpfulness of the 
survivorship care plans will vary according to the quality of the care plan as well as the 
preexisting knowledge base of the patients. Although those questions provide a measure of 
the use of care plans in the patient population, the authors could not distinguish whether any 
lack of helpfulness was caused by a failure of the care plan document or simply because 
patients already possessed the knowledge.
Conclusion
Patients with breast and colorectal cancer were quite satisfied with the survivorship care 
plans and reported that the various components of the care plan were important in helping 
them understand their diagnosis, treatment, and survivorship care. Although the impact of 
survivorship care plans on health outcomes remains unclear, the results indicate that patients 
find them highly valuable. The survivorship care plans were most highly valued by patients 
for helping them understand the need for follow-up visits to check for late effects and the 
importance of health promoting practices following cancer treatment. Future efforts to 
improve survivorship care plans should focus on describing the coordination of survivorship 
care, including improved delineation of the specific roles of the primary care provider and 
oncologist.
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Implications for Practice
► Survivorship care plans are useful tools for improving how patients with 
cancer understand their diagnosis, treatment, survivorship care, and health 
promotion.
► Survivorship care plans partially reduce patient uncertainty regarding the 
coordination of survivorship care between primary care providers and 
oncologists.
► Future efforts to ensure improved coordination of care will require 
improvements to current survivorship care plan designs and/or additional 
efforts beyond the provision of a survivorship care plan.
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FIGURE 1. 
Understanding Specific Elements of Care Through the Cancer Survivorship Plan (N = 58)
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TABLE 1
Characteristics of the Study Population (N = 58)
Breast
(n = 48)
Colorectal
(n = 10)
Characteristic n n
Facility
  Urban academic medical center 30 7
  Rural community hospital 18 3
Age (years)
  35–49 12 3
  50–64 25 3
  65–75 11 4
Education
  No college 11 5
  Some college 14 1
  College graduate 23 4
Marital status
  Married, civil union, or partner 36 7
  Widowed, separated, or divorced 9 2
  Never married 3 1
Annual family income ($)a
  Less than 35,000 5 1
  35,000–75,000 17 2
  More than 75,000 19 4
Self-rated overall health
  Poor 3 –
  Fair 3 –
  Good 22 3
  Very good 15 4
  Excellent 5 3
Cancer stage
  0 4 –
  I 25 –
  II 15 2
  III 4 7
  IV – 1
Treatments receivedb
  Surgery 48 10
  Radiation 45 2
  Chemotherapy 25 10
  Hormone therapy 38 –
a
Data on income were missing for seven patients with breast cancer and three patients with colorectal cancer.
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b
Most patients received more than one treatment.
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TABLE 2
Patient Satisfaction With the Survivorship Care Plan (N = 58)
Breast
(n = 48)
Colorectal
(n = 10)
Variable n n
Overall satisfaction with care plan
  Not at all satisfied 1 –
  Indifferent 2 1
  Somewhat satisfied 7 1
  Very satisfied 23 7
  Completely satisfied 15 1
Care plan was useful.
  Strongly disagree – –
  Disagree 2 –
  Neither agree nor disagree 3 –
  Agree 11 3
  Strongly agree 32 7
Care plan was easy to understand.
  Strongly disagree – –
  Disagree – –
  Neither agree nor disagree 2 –
  Agree 11 5
  Strongly agree 35 5
Length was just right.a
  Strongly disagree – –
  Disagree – –
  Neither agree nor disagree 3 –
  Agree 8 4
  Strongly agree 36 6
Would need help using care plan.
  Strongly disagree 23 3
  Disagree 14 3
  Neither agree nor disagree 4 –
  Agree 7 3
  Strongly agree – 1
Care plan visit was useful.
  Not at all useful 1 –
  Somewhat useful 7 –
  Very useful 40 10
Would recommend a care plan to others.
  No 1 –
  Yes 47 10
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a
Data were missing for one patient with breast cancer regarding length of the survivorship care plan.
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TABLE 3
Patient Evaluation of Specific Survivorship Care Plan Domains (N = 58)
Breast (n = 48) Colorectal (n = 10)
Variable na % 95% Cl na % 95% Cl
Information was accurate.
  Diagnosis information 43 90 [77.3, 96.5] 9 90 [55.5, 99.8]
  Treatment information 41 85 [72.2, 93.9] 7 70 [34.8, 0.93]
Easy to understand
  Diagnosis information 44 92 [80, 97.7] 10 100 [69.2, 100]
  Treatment information 45 94 [82.8, 98.7] 9 90 [55.5, 99.8]
  Which doctor will order tests to detect recurrences or new cancers 28 58 [43.2, 72.4] 7 70 [34.8, 93.3]
  Possible long-term and late effects 40 83 [69.8, 92.5] 9 90 [55.5, 99.8]
  Resources available to you 43 92 [79.6, 97.6] 9 90 [55.5, 99.8]
Care plan was very or critically important to help understand
  Your diagnosis 22 50 [34.6, 65.4] 9 90 [55.5, 99.8]
  Treatments you received 28 61 [45.4, 74.9] 9 90 [55.5, 99.8]
  Tests needed in the future to detect recurrences or new cancers 32 70 [54.3, 82.3] 10 100 [69.2, 100]
  Possible long-term and late effects 28 60 [44.3, 73.6] 8 80 [44.4, 97.5]
  Resources available to you 25 54 [39, 69.1] 8 80 [44.4, 97.5]
aNumber of subjects agreeing
Cl—confidence interval
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